Streptococcus Pneumoniae: Clinical Trials

1 trial for Streptococcus Pneumoniae, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Streptococcus Pneumoniae: new trials by email Literature Review of Streptococcus Pneumoniae trials Research Report on Streptococcus Pneumoniae

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma
Prevenar 13 + Pneumovax 23, PREVENAR20 - Vaccine, Streptococcus Pneumoniae
Phase 4RecruitingPoitiers University Hospital1602021-09-072026-05-29

Narrower conditions

Lymphoma, Non-Hodgkin (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

13-valent pneumococcal vaccine (1)  ·  23-valent pneumococcal capsular polysaccharide vaccine (1)

Sponsors

Poitiers University Hospital (1)

Countries

France (1)